Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage IVA-B Head and Neck Cancer

Conditions:   Larynx;   Lip, Oral Cavity and Pharynx
Interventions:   Biological: Nivolumab;   Biological: Ipilimumab;   Radiation: Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy;   Radiation: Volume Modulated Arc Therapy
Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Bristol-Myers Squibb
Recruiting - verified May 2017

http://ift.tt/2q37NTN